Champions Oncology Inc Stock
Price
Target price
€6.15
€6.15
18.270%
0.95
18.270%
-
13.06.25 / Frankfurt
WKN: A14X6S / Name: Champions / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Champions Oncology Inc Stock
Champions Oncology Inc dominated the market today, gaining €0.95 (18.270%).
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | 18.270% | 9.821% | 8.850% | 30.297% | 29.202% | -16.892% | -20.645% |
| Krystal Biotech | -1.400% | -1.083% | 1.757% | -28.507% | -21.978% | 132.843% | - |
| Ardelyx Inc. | -0.560% | -0.744% | 5.748% | -46.002% | -35.529% | 521.071% | -45.282% |
| Evolus Inc | -1.730% | 3.030% | -3.955% | -19.048% | -19.048% | -23.423% | 95.853% |
News
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading technology-enabled oncology research organization with specialty testing services, is excited
